Related references
Note: Only part of the references are listed.Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis
Simone Kreutmayer et al.
CELL STRESS & CHAPERONES (2013)
Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection
Anyou Wang et al.
CELLULAR MICROBIOLOGY (2013)
THE ELUSIVE BUT PATHOGENIC PEPTIDOGLYCAN OF CHLAMYDIAE
M. Di Pietro et al.
EUROPEAN JOURNAL OF INFLAMMATION (2013)
Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?
M. Di Pietro et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Oxidative stress in vascular disease and its pharmacological prevention
Huige Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species
Jennifer Rivera et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease
Kai Chen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2012)
Platelets: key players in vascular inflammation
Delia Projahn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Chlamydophila (Chlamydia) pneumoniae infection promotes vascular smooth muscle cell adhesion and migration through IQ domain GTPase-activating protein 1
Lijun Zhang et al.
MICROBIAL PATHOGENESIS (2012)
GroEL1, from Chlamydia pneumoniae, Induces Vascular Adhesion Molecule 1 Expression by p37AUF1 in Endothelial Cells and Hypercholesterolemic Rabbit
Chun-Yao Huang et al.
PLOS ONE (2012)
Critical Role of the Nitric Oxide/Reactive Oxygen Species Balance in Endothelial Progenitor Dysfunction
Felix Fleissner et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells
Mirna N. Chahine et al.
CARDIOVASCULAR RESEARCH (2011)
Chlamydia pneumoniae Heat Shock Protein 60 Enhances Expression of ERK, TLR-4 and IL-8 in Atheromatous Plaques of Coronary Artery Disease Patients
Hem C. Jha et al.
IMMUNOLOGICAL INVESTIGATIONS (2011)
GroEL1, a Heat Shock Protein 60 of Chlamydia pneumoniae, Induces Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Expression in Endothelial Cells and Enhances Atherogenesis in Hypercholesterolemic Rabbits
Feng-Yen Lin et al.
JOURNAL OF IMMUNOLOGY (2011)
NOX Isoforms and Reactive Oxygen Species in Vascular Health
Rhian M. Touyz et al.
MOLECULAR INTERVENTIONS (2011)
Chlamydia pneumoniae Induces Chemokine Expression by Platelets in Patients with Atherosclerosis
Abdelhad Al-Bannawi et al.
MEDICAL PRINCIPLES AND PRACTICE (2011)
Chlamydia persistence - a tool to dissect chlamydia-host interactions
R. V. Schoborg
MICROBES AND INFECTION (2011)
Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis
Michael E. Rosenfeld et al.
THROMBOSIS AND HAEMOSTASIS (2011)
INDUCED EXPRESSION OF LECTIN-LIKE OXIDIZED LDL RECEPTOR-1 IN VASCULAR SMOOTH MUSCLE CELLS FOLLOWING CHLAMYDIA PNEUMONIAE INFECTION AND ITS DOWN-REGULATION BY FLUVASTATIN
D. Prochnau et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2010)
Is oxidative stress a therapeutic target in cardiovascular disease?
Thomas Muenzel et al.
EUROPEAN HEART JOURNAL (2010)
Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis
Justin F. Deniset et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice
Shuang Chen et al.
JOURNAL OF IMMUNOLOGY (2010)
Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways
Wei Liu et al.
MICROBES AND INFECTION (2010)
Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke
Berna Atik et al.
PLOS ONE (2010)
Statin Therapy-Part II: Clinical Considerations for Cardiovascular Disease
Benjamin Sadowitz et al.
VASCULAR AND ENDOVASCULAR SURGERY (2010)
Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients
Hem C. Jha et al.
APMIS (2009)
Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells
Changyi Chen et al.
CARDIOVASCULAR RESEARCH (2009)
Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR α and PPAR γ-dependent pathways
Chun-li Mei et al.
CELL BIOLOGY INTERNATIONAL (2009)
The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced
Andreas Klos et al.
FEMS MICROBIOLOGY LETTERS (2009)
Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells
Anna Oksaharju et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes From the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Trial
Sabina A. Murphy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A: cholesterol acyltransferase 1
Ping He et al.
MICROBES AND INFECTION (2009)
Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae
M. Hogdahl et al.
APMIS (2008)
Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease
Hem Chandra Jha et al.
JOURNAL OF CARDIOLOGY (2008)
Chlamydophilal antigens induce foam cell formation via c-Jun NH2-terminal kinase
Takatoshi Kitazawa et al.
MICROBES AND INFECTION (2007)
Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors
Hanna Kalvegren et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease
Shaoshan S. Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Chlamydia pneumonia-induced macrophage foam cell formation is mediated by toll-like receptor 2
Fei Cao et al.
INFECTION AND IMMUNITY (2007)
Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein - Induced cell death in human endothelial cells, leading to necrosis rather than apoptosis
D Nazzal et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Macrophage antioxidant enzymes regulate Chlamydia pneumoniae chronicity: Evidence of the effect of redox balance on host-pathogen relationship
Anthony A. Azenabor et al.
IMMUNOBIOLOGY (2006)
Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells
X Yang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells
JJM Bouwman et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Silencing or permanent activation:: host-cell responses in models of persistent Chlamydia pneumoniae infection
J Peters et al.
CELLULAR MICROBIOLOGY (2005)
Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 cells
G Deby-Dupont et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway
K Yaraei et al.
INFECTION AND IMMUNITY (2005)
Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice
CS Little et al.
INFECTION AND IMMUNITY (2005)
Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: a Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes
AA Azenabor et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2005)
Chlamydia pneumoniae infections in mouse models:: relevance for atherosclerosis research
MD de Kruif et al.
CARDIOVASCULAR RESEARCH (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Chlamydial persistence: beyond the biphasic paradigm
RJ Hogan et al.
INFECTION AND IMMUNITY (2004)
Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries
R Sessa et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2004)
Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1)
A Mouithys-Mickalad et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Autoimmune and inflammatory mechanisms in atherosclerosis
G Wick et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture
L Mannonen et al.
MICROBIAL PATHOGENESIS (2004)
Induction of lipoprotein lipase gene expression in Chlamydia pneumoniae-infected macrophages is dependent on Ca2+ signaling events
AA Azenabor et al.
BIOLOGICAL CHEMISTRY (2004)
Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60
S Hirono et al.
CIRCULATION RESEARCH (2003)
Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation
R Dechend et al.
CIRCULATION (2003)
Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice
R Ezzahiri et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2003)
Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease:: a systematic review -: art. no. 21
M Smieja et al.
BMC INFECTIOUS DISEASES (2002)
Chlamydia pneumoniae and atherosclerosis: Critical assessment of diagnostic methods and relevance to treatment studies
J Boman et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease
R Sessa et al.
ATHEROSCLEROSIS (2001)
Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice
E Blessing et al.
ATHEROSCLEROSIS (2001)
Standardizing Chlamydia pneumoniae assays:: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)
SF Dowell et al.
CLINICAL INFECTIOUS DISEASES (2001)
Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation
S Sasu et al.
CIRCULATION RESEARCH (2001)
Interactions of Chlamydia pneumoniae with human endothelial cells
JT Summersgill et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Chlamydia pneumoniae-induced atherosclerosis in a rabbit model
JB Muhlestein
JOURNAL OF INFECTIOUS DISEASES (2000)
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
JT Grayston
JOURNAL OF INFECTIOUS DISEASES (2000)
Growth in vascular cells and cytokine production by Chlamydia pneumoniae
CA Gaydos
JOURNAL OF INFECTIOUS DISEASES (2000)
Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
H Kothe et al.
CIRCULATION (2000)
Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens
P Apfalter et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Share Paper
